MedPath

Multidisciplinary Program of Treatment of Obesity: Evaluation of Cardiometabolic Risk Factors

Not Applicable
Recruiting
Conditions
Overweight
Obesity
Abdominal Obesity
Morbid Obesity
C23.888.144.699
C18.654.726.500
C18.654.726.500.697
C18.654.726.500.700
Registration Number
RBR-2yzs76
Lead Sponsor
niversidade Estadual de Maringá
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age between 18 and 50 years; Being overweight or obese, from cutting index points Body mass index greater than or equal 25; Waist circumference greater than or equal 88 cm for women and greater than or equal 102 cm for men; Be resident in Maringa or Maringá metropolitan area; Present willingness to participate in the evaluations of the risk cardiometabólico; Agree and sign the informed consent approved by the local Ethics Committee.

Exclusion Criteria

Recent abdominal surgery or Bariatric Surgery;
Pulmonary disease with oxygen dependence; Hospitalization for treatment of cardiovascular diseases in the last 6 months; Aortic stenosis;
Being pregnant or have less than 3 months post partum; Use of medicines for weight loss; Using glicocorticoides;

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome 1 provided for this study will be anthropometric parameters (body weight, BMI and waist circumference).;The primary outcome 2 planned for the present study will be parameters of body composition (fat mass, fat%, fat free mass, fat free mass%).
Secondary Outcome Measures
NameTimeMethod
The secondary outcome 1 provided for this study will be the metabolic changes (blood glucose, glycated hemoglobin, insulinemia and lipid profile).;The secondary outcome 2 planned for the present study is physical fitness (flexibility, strength/muscular endurance and cardio-respiratory fitness).;The secondary outcome 3 provided for this study will be the inflammatory parameter measured by C-reactive protein ultra sensible.;The secondary outcome 4 referred to the present study are the cardiovascular parameters (heart rate variability, systolic and diastolic blood pressure, carotid intimal middle layer and cardiac geometry).;The secondary outcome 5 scheduled for the present study is the change in lifestyle measured by assessment instruments<br>readiness for change, quality of life, physical activity level and eating habits.
© Copyright 2025. All Rights Reserved by MedPath